Gilead Sciences Partners With White House for Early Cancer Detection Program “Biden Cancer Moonshot”

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Gilead Sciences:

In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonshot recently announced a series of actions that organizations are taking to improve access and use of cancer screenings. We’re proud to be included on the list for our commitment to help increase screening rates among employees through personalized outreach.

https://gilead.inc/4aqS42d

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:

Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences

View the original press release on accesswire.com

Staff

Recent Posts

BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference

Vancouver, British Columbia--(Newsfile Corp. - January 7, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB:…

2 hours ago

Q2i Secures Patent for PARCA Solution, Revolutionizing Probation and Parole

BOSTON, Jan. 7, 2025 /PRNewswire/ -- Q2i, a leader in digital innovation, is proud to announce…

2 hours ago

McDermott Appoints Krist Werling to Lead Best-In-Class Global Health & Life Sciences Practice

CHICAGO, Jan. 7, 2025 /PRNewswire/ -- International law firm McDermott Will & Emery has appointed Kristian (Krist)…

2 hours ago

DeepScribe receives 98.8* overall performance score in KLAS Research report, with top grades in every category

The KLAS Emerging Company Spotlight includes 15 A+* grades for performance indicators across six categories, based…

2 hours ago

GlobalVetLink Unveils New HorseSync Progressive Web Application to Support Streamlined Workflows for Equine Veterinary Clinics

AMES, Iowa, Jan. 7, 2025 /PRNewswire/ -- Equine veterinarians face the constant challenge of managing…

2 hours ago

Arbital Health Expands Value-Based Care Contracting Capabilities with Acquisition of Senior Actuary Team

Transaction adds 35 new client relationships and broadens capabilities for Arbital Health's technology platform and…

2 hours ago